NEW YORK ( TheStreet) -- With a small-cap rally leading 2009 equity gains, conventional market wisdom dictates that large-cap companies in the health care sector should receive more attention in 2010.
Sarepta Therapeutics, Paratek Pharmaceuticals and PDL BioPharma were among the biotech stock movers in premarket trading on Monday.
Doug Kass shares his thoughts on Apple, Allergan and Western Digital.
Eli Lilly has become the new go-to name in the pharmaceutical space, even over Johnson & Johnson, Cramer said.
'These companies are all assessing the Trump effect,' Cramer said.